Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery

M Simons1, E R Edelman, R D Rosenberg

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.

Insights

Antisense oligonucleotides targeting proliferating cell nuclear antigen (PCNA) significantly reduced smooth muscle cell proliferation and neointimal accumulation in a rat carotid artery injury model. PCNA expression is essential for smooth muscle cell growth and neointimal formation post-injury.

Area of Science:

  • Vascular biology
  • Cellular and molecular medicine
  • Cardiovascular research

Background:

  • Vascular injury triggers smooth muscle cell proliferation and migration, leading to neointimal hyperplasia.
  • Proliferating cell nuclear antigen (PCNA) is a key marker of cell proliferation and DNA synthesis.

Purpose of the Study:

  • To investigate the role of PCNA in smooth muscle cell proliferation and neointimal accumulation following arterial injury.
  • To determine if inhibiting PCNA expression can prevent neointimal formation in a rat carotid artery injury model.

Main Methods:

  • Antisense phosphorothioate oligonucleotides were used to inhibit PCNA expression in a rat carotid artery injury model.
  • PCNA mRNA and protein levels were assessed via RT-PCR and immunohistochemistry.
  • Cell proliferation was measured using BrdU incorporation.
  • Neointimal area was quantified morphometrically.

Main Results:

  • Extraluminal delivery of antisense oligonucleotides targeting PCNA suppressed PCNA mRNA by 77% and protein expression by 52%.
  • PCNA inhibition reduced smooth muscle cell proliferation by 59% and neointimal accumulation by 80% at 2 weeks post-injury.
  • Control oligonucleotides had no significant effect on PCNA expression or neointimal formation.

Conclusions:

  • PCNA expression is critical for medial smooth muscle cell proliferation in vivo.
  • Inhibition of PCNA effectively reduces neointimal formation after vascular injury.
  • Targeting PCNA represents a potential therapeutic strategy for preventing vascular restenosis.

Related Concept Videos